News Image

Should you consider NASDAQ:BLBD for growth investing?

By Mill Chart

Last update: Feb 13, 2024

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if BLUE BIRD CORP (NASDAQ:BLBD) is suited for growth investing. Investors should of course do their own research, but we spotted BLUE BIRD CORP showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Why NASDAQ:BLBD may be interesting for growth investors.

  • BLUE BIRD CORP exhibits a strong Return on Equity (ROE) of 81.07%, indicating the company's ability to generate solid returns on shareholder investments. This metric reflects the company's efficient utilization of equity capital and its profitability.
  • BLUE BIRD CORP has consistently exceeded EPS estimates in the last 4 quarters, demonstrating its ability to outperform market expectations. This trend highlights the company's strong financial performance and its potential for future growth.
  • BLUE BIRD CORP has achieved significant 1-year revenue growth of 33.9%, signaling its ability to capture market opportunities and drive top-line expansion. This growth indicates the company's effective execution and its potential for continued success.
  • With impressive quarter-to-quarter (Q2Q) revenue growth of 34.77%, BLUE BIRD CORP showcases its ability to generate increased sales and revenue. This growth indicates the company's strong customer demand and its effective business strategies.
  • With positive growth in its operating margin over the past year, BLUE BIRD CORP showcases its ability to improve profitability through effective cost control and operational efficiency. This growth underscores the company's commitment to enhancing its financial performance.
  • With positive growth in its free cash flow (FCF) over the past year, BLUE BIRD CORP showcases its ability to generate strong cash flows and maintain a solid financial position. This growth reflects the company's efficient utilization of capital and its commitment to long-term value creation.
  • The EPS of BLUE BIRD CORP has exhibited growth from one quarter to another (Q2Q), with a 403.0% increase. This underscores the company's ability to generate higher earnings and improve its financial standing.
  • The average next Quarter EPS Estimate for BLUE BIRD CORP has experienced a 212.0% change in the last 3 months, reflecting evolving expectations by analysts regarding the company's EPS performance.
  • In the most recent financial report, BLUE BIRD CORP reported a 403.0% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
  • BLUE BIRD CORP shows accelerating EPS growth: when comparing the current Q2Q growth of 403.0% to the previous year Q2Q growth of -329.0%, we see the growth rate improving.

How does the complete fundamental picture look for NASDAQ:BLBD?

ChartMill employs a sophisticated system to assign a Fundamental Rating to every stock in its analysis. This rating, which ranges from 0 to 10, is determined by carefully assessing multiple fundamental indicators and properties.

Taking everything into account, BLBD scores 5 out of 10 in our fundamental rating. BLBD was compared to 133 industry peers in the Machinery industry. BLBD has only an average score on both its financial health and profitability. An interesting combination arises when we look at growth and value: BLBD is growing strongly while it also seems undervalued. With these ratings, BLBD could be worth investigating further for value and growth investing!.

Our latest full fundamental report of BLBD contains the most current fundamental analsysis.

More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

BLUE BIRD CORP

NASDAQ:BLBD (4/23/2024, 7:00:01 PM)

After market: 37 +0.71 (+1.96%)

36.29

+2.31 (+6.8%)

BLBD News

News Image7 days ago - ChartmillShould you consider BLUE BIRD CORP (NASDAQ:BLBD) for growth investing?

Why the growth investor may take a look at BLUE BIRD CORP (NASDAQ:BLBD).

News Image8 days ago - ChartmillLooking for growth without the hefty price tag? Consider NASDAQ:BLBD.

While growth is established for BLUE BIRD CORP (NASDAQ:BLBD), the stock's valuation remains reasonable.

News Image14 days ago - InvestorPlaceAhead of the Curve: 7 Stocks to Buy Before They Go Mainstream

Discover seven overlooked stocks to buy poised for 10X returns across diverse industries. Unlock their growth potential now.

News Image16 days ago - ChartmillDespite its impressive fundamentals, NASDAQ:BLBD remains undervalued.

Investors should take notice ofBLUE BIRD CORP (NASDAQ:BLBD)—it offers a great deal for the fundamentals it presents.

News Imagea month ago - InvestorPlace7 EV Stocks That Could Be Multibaggers in the Making: March Edition

Discover EV stocks poised for explosive growth, tapping into cutting-edge technology and market dominance.

News Imagea month ago - InvestorPlace3 Promising Small-Cap Stocks Packing a Powerful Punch

Here're three under-the-radar small-cap stocks with robust growth potential that could deliver outsized returns for risk-tolerant investors.

News Image2 months ago - InvestorPlaceBeat Wall Street: 3 Stocks Flying Under the Radar

The market is full of many companies that most people haven’t even heard of. Add these stocks to your portfolio that fly under the radar.

News Image2 months ago - InvestorPlace7 Must-Buy Stocks for a Diversified High-Growth Portfolio

Explore how these high-growth portfolio stocks can drive substantial returns in IT, communication, industrials, and financials.

News Image2 months ago - NewsfileAdaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...

News Image2 months ago - InvestorPlaceWall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024

Though the certainty of the electric vehicle industry may be waning, these three EV stocks offer strong potential nonetheless.

News Image2 months ago - InvestorPlace3 Goliath Growth Stocks Poised for Takeoff in February

These three top-tier growth stocks to buy offer investors incredible potential returns and are perfect for long-term investing.

News Image2 months ago - Seeking AlphaAmerican Securities to sell 4.04M shares in Blue Bird (NASDAQ:BLBD)

Blue Bird announces American Securities affiliate to offer 4.04M shares of common stock, resulting in a 5.55% drop in extended trading.

BLBD Links
Follow us for more